3,861 Shares in SPDR S&P Biotech ETF $XBI Bought by National Wealth Management Group LLC

National Wealth Management Group LLC acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 3,861 shares of the exchange traded fund’s stock, valued at approximately $609,000.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Vertrix Wealth Management LLC raised its position in SPDR S&P Biotech ETF by 5.0% in the 3rd quarter. Vertrix Wealth Management LLC now owns 1,503 shares of the exchange traded fund’s stock worth $237,000 after purchasing an additional 71 shares during the period. Compound Planning Inc. grew its position in SPDR S&P Biotech ETF by 0.7% during the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after acquiring an additional 75 shares during the last quarter. PeakShares LLC increased its stake in SPDR S&P Biotech ETF by 5.2% in the 1st quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock worth $215,000 after purchasing an additional 84 shares during the period. Robertson Stephens Wealth Management LLC increased its stake in SPDR S&P Biotech ETF by 0.5% in the 3rd quarter. Robertson Stephens Wealth Management LLC now owns 21,640 shares of the exchange traded fund’s stock worth $3,412,000 after purchasing an additional 99 shares during the period. Finally, Compass Ion Advisors LLC increased its stake in SPDR S&P Biotech ETF by 3.0% in the 3rd quarter. Compass Ion Advisors LLC now owns 3,993 shares of the exchange traded fund’s stock worth $630,000 after purchasing an additional 117 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI stock opened at $150.47 on Tuesday. SPDR S&P Biotech ETF has a fifty-two week low of $106.30 and a fifty-two week high of $169.89. The stock has a 50 day moving average price of $157.13 and a two-hundred day moving average price of $140.94. The company has a market capitalization of $10.50 billion, a P/E ratio of 11.47 and a beta of 0.83.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.